跳至主要内容
临床试验/2024-520392-27-00
2024-520392-27-00招募中2 期

Visualizing beta cells in patients with a history of gestational diabetes.

Radboud universitair medisch centrum Stichting1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2025年1月13日最近更新:
相关药物

试验速览

阶段
2 期
状态
招募中
入组人数
24
试验地点
1
主要终点
The main parameter of the study is the quantitative assessment of pancreatic 68Ga-NODAGA-exendin-4 uptake women with and without a history of GDM by PET/CT.

研究概览

简要总结

The primary objective is to evaluate the difference in 68Ga-exendin tracer accumulation in the pancreas of patients with and without a history of gestational diabetes by quantitative analysis of PET images.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 64 years(18-64 Years)
接受健康志愿者

入选标准

  • Pregnancy with diagnosis of GDM, within the last 5 years
  • No other previous pregnancies
  • Complete resolution of GDM after delivery (HbAlc in normal range, fasting glucose < 1OO mg/dl for at least I year in the absence of active pharmacologic therapy or ongoing procedures)
  • Signed informed consent

排除标准

  • Previous treatment (within 6 months) with synthetic Exendin (Exenatide, Byetta@) or Dipeptidyl-Peptidase IV inhibitors
  • Breast feeding
  • Current pregnancy or the wish to become pregnant within 6 months
  • Renal dysfunction (Calculated creatinine clearance below 40 ml/min)
  • Liver disease defined as aspartate aminotransferase or alan¡ne aminotransferase level of more than three times the upper limit of normal range
  • Age < 18 years
  • incapacitated
  • no signed informed consent

结局指标

主要结局

The main parameter of the study is the quantitative assessment of pancreatic 68Ga-NODAGA-exendin-4 uptake women with and without a history of GDM by PET/CT.

The main parameter of the study is the quantitative assessment of pancreatic 68Ga-NODAGA-exendin-4 uptake women with and without a history of GDM by PET/CT.

次要结局

  • The correlation between Ga-exendin tracer accumulation and beta cell function of the subjects

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Sevilay Tokgöz

Scientific

Radboud universitair medisch centrum Stichting

研究点 (1)

Loading locations...

相似试验

招募中
2 期
Visualizing beta cells in patients with a history of gestational diabetesGestational diabetespregnancy diabetes10018424
NL-OMON47071ucleaire geneeskunde en radiologie24
进行中(未招募)
不适用
Visualizing beta cells in patients with remission of T2DM after bariatric surgeryPatients with Type 2 Diabetes, with or without remission after bariatric surgeryMedDRA version: 17.1Level: HLGTClassification code 10018424Term: Glucose metabolism disorders (incl diabetes mellitus)System Organ Class: 10014698 - Endocrine disordersMedDRA version: 17.1Level: HLTClassification code 10012602Term: Diabetes mellitus (incl subtypes)System Organ Class: 10014698 - Endocrine disordersMedDRA version: 17.1Level: PTClassification code 10012601Term: Diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disorders
EUCTR2014-004317-90-NLRadboud University Medical Center Nijmegen24
招募中
不适用
Visualizing beta cells in patients with remission of T2DM after bariatric surgery1001842410017998Type 2 Diabetes
NL-OMON42279niversitair Medisch Centrum Sint Radboud24
招募中
不适用
Visualizing beta cells in patients with (postprandial) hyperinsulinemic hypoglycemia after bariatric surgeryhyperinsulinemic hypoglycaemialow blood glucose caused by excessive insulin1001842410017998
NL-OMON44909Radboud Universitair Medisch Centrum24
进行中(未招募)
不适用
Visualizing Beta Cells in Patients With a History of Gestational DiabetesGestational Diabetes
NCT03182296Radboud University Medical Center24
Imaging beta cells after gestational diabetes | 临床试验